Note: Ingredients listed on restricted chemical lists
EC/CAS
209-150-3
Name of the chemical
Aluminium, zinc, magnesium and calcium stearates
Concentration
N/A
General Information
Revision date
2015-01-07
Product name
TAFINLAR CAPSULES
Product Synonyms
TAFINLAR CAPSULES 50 MG * TAFINLAR CAPSULES 75 MG * DABRAFENIB CAPSULES *
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
Section 2
EU Classification
Directive 67/548/EEC or 1999/45/EC as amended Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device. Regulation (EC) No 1272/2008 as amended Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device.
2.3 Other hazards
Caution - Pharmaceutical agent. Occupational exposure to the substance or mixture may cause adverse health effects. Not expected to be a significant health hazard unless product is crushed or broken. See section 11 for additional information on health hazards. This product contains an ingredient(s) that is toxic to aquatic organisms.
